The chemical class referred to as FucT-VIII Inhibitors comprises a group of small organic molecules that are specifically designed to modulate the activity of the Fucosyltransferase VIII enzyme (FucT-VIII). FucT-VIII is an essential enzyme involved in a glycosylation process that influences the addition of fucose residues to certain biomolecules. Inhibition of FucT-VIII can lead to alterations in fucosylation patterns of various molecules within biological systems. Members of this chemical class are characterized by their structural features, which allow them to selectively interact with the active site or other functionally significant regions of the FucT-VIII enzyme.
These inhibitors are designed to interfere with the enzyme's catalytic function, leading to changes in the fucosylation status of specific biomolecules. The exploration and development of FucT-VIII inhibitors contribute to advancing our understanding of glycosylation processes and their potential biological implications. Researchers continue to study these inhibitors to elucidate their effects on cellular and molecular processes, thereby expanding our knowledge of glycosylation-related mechanisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Desmopressin | 16679-58-6 | sc-391126 | 1 mg | $138.00 | ||
While not a direct inhibitor, desmopressin is used for certain types of mild hemophilia A by stimulating the release of stored Factor VIII from endothelial cells. | ||||||